DNAprint Genomics (DNAG)

[stockhlder101]

THE BIG 10/07 conference> (tony, yeatman, Merck) http://www.allconferences.com/conferences/20070403092437/

1st Annual Total Cancer Care Summit: The Future of Personalized Medicine
Date: Wednesday, October 24, 2007 - Sunday, October 28, 2007
Location: Atlantis, Paradise Island, Bahamas
Description:



Welcome!


The H. Lee Moffitt Cancer Center & Research Institute and University of South Florida are proud to sponsor the first annual Total Cancer Care Summit. This innovative conference will focus on the prospect of developing a one of a kind integrated data repository, pairing molecular and clinical data, which will be the mechanism to find the right drug for the right patient. This first annual meeting will take place from Wednesday, October 24th, 2007 through Sunday, October 27th, 2007 at the Atlantis Resort on Paradise Island in the Bahamas. The Course Director, Dr. Timothy Yeatman, and the Planning Committee, have organized an outstanding program.

THIS PART LOOKS LIKE M2GEN...most
Session 3: Developing Genetic Signatures for Clinical Practice Chairperson: Johnathan Lancaster, M.D., Ph.D., H. Lee MoffittCancer Center & Research Institute at the University of South Florida Tailoring Therapy for Women with Ovarian Cancer: The Power of Genomics Johnathan Lancaster, M.D., Ph.D., H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida The Use of Cancer Biomarkers in Development of Targeted Therapies Peter Shaw, Ph.D., Merck & Co., Inc.

The Role of SNPs in Predicting Drug ToxicityTony N. Frudakis, Ph.D., DNAPrint Genomics, Inc.

Lung Cancer and Genomic Signatures – Changing Treatment Paradigms Gerold Bepler, M.D., Ph.D., H. Lee Moffitt Cancer Center &Research Institute at the University of South Florida Mathematical Models, Molecular Signatures and the Predictionof Response to Radiation Therapy Javier F. Torres-Roca, M.D., H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida10:30 – 11:00 a.m. Break 11:00 – 1:00 p.m. Session 4: Can Genetic Markers Predict Clinical Outcomes? Chairperson: Dan Sullivan, M.D., H. Lee Moffitt Cancer Center &
--------------------------------------------------------------------------------
Page 3
Research Institute at the University of South Florida Personalizing Therapy and Diagnosis for Colorectal Cancer Using Gene Expression Profiles Steven A. Eschrich, Ph.D., H. Lee Moffitt Cancer Center &Research Institute at the University of South Florida A 3-D View of Genetics: Leveraging Multiple Technologies toUnderstand the Human Blueprint John Cowell, Ph.D., D.Sc., FRCPath, Roswell Park Cancer InstituteFunctional Genomics in Drug Discovery: The Future of Personalized Cancer CareHans Winkler, Johnson & Johnson Pharmaceutical Research & Development 1:00 – 2:30 p.m. Lunch Discussion: The Future of Personalized Medicine:Partnerships Between Academia and Industry William Dalton, Ph.D., M.D., H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida Stephen Friend, M.D., Ph.D., Merck Research Laboratories2:30 – 3:30 p.m. Session 5: Role of Health Outcomes in Personalized MedicineChairperson: Paul Jacobsen, Ph.D., H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida Quality of Life and Personalized MedicineDavid Cella, Ph.D., Evanston Northwestern Healthcare and Northwestern UniversityQuality of Cancer CareJoe Simone, M.D., Simone Consulting Saturday, October 27, 2007 7:00 – 8:00 a.m. Breakfast 8:00 – 10:00 a.m. Session 6: Revolutionizing Clinical Trials through PatientMatching Chairperson: Timothy Yeatman, M.D., F.A.C.S., H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida Total Cancer CareTimothy Yeatman, M.D., F.A.C.S., H. Lee Moffitt Cancer Center & Research Institute at the University of South FloridaBridging the Gap: The Contract Research Organization’s Role in Providing Infrastructure for Multi-Center Clinical Trials Jake Vinson, M.H.A., Hoosier Oncology Group, LLC
--------------------------------------------------------------------------------
Page 4
Biobanking for Cancer Research Tyron Hoover, M.D., J.D., H. Lee Moffitt Cancer Center &Research Institute at the University of South Florida10:00 – 10:30 a.m. Break 10:30 – 12:30 p.m. Session 7: The Future of Personalized Medicine: New Targets, New Imaging Technologies, New Trial Designs Chairperson: Timothy Yeatman, M.D., F.A.C.S., H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida Targeting Patients Whose Tumors Depend on AKTSaid Sebti, Ph.D., H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida Honing in on Drug Targets Hong-Gang Wang, Ph.D., H. Lee Moffitt Cancer Center &Research Institute at the University of South Florida New Trial DesignsDan Sullivan, M.D., H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida New Imaging TechnologyTBD Sunday, October 28, 2007 8:00 – 9:30 a.m. Breakfast Roundtable Discussion: New Treatment Paradigms in Personalized Medicine9:30 – 10:00 a.m. Closing Remarks Timothy Yeatman, M.D., F.A.C.S., H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida Program and speakers are subject to change.